Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
- Type: E-Poster
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
- Presentations: 26
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP07.01-021 - Clinical and Biochemical Profiling of Pleural Mesothelioma Patients Treated With Immunotherapy
Author(s): Mario Occhipinti- Abstract
Loading...
-
+
EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 108
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.01-006 - Using Real World data to build effective predictive machine learining models for NSCLC patients treated with immune-based therapy
Author(s): Arsela Prelaj- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 171
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-060 - How Do Oncologists Treat Patients With EGFR Exon-20 Mutant NSCLC Outside of Clinical Trials? Updated Analysis From the European EXOTIC Registry
Author(s): Giannis Mountzios- Abstract
Loading...
-
+
P1.15 - Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Type: Regular Poster
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 12
- Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
-
+
P1.15-02 - Plasma microRNAs Modulation in Advanced NSCLC Patients Receiving Single Agent Immune Checkpoint Inhibitors
Author(s): Claudia Proto- Abstract
Loading...
-
+
MA10 - Updates in Thymoma
- Type: Mini Oral
- Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
- Presentations: 13
- Moderators:Noboru Yamamoto
- Coordinates: 8/08/2022, 14:45 - 15:45, Hall C8
-
+
MA10.07 - Phase II Trial of Sunitinib in Patients with Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines - STYLE Trial (NCT03449173)
15:12 - 15:17 | Author(s): Claudia Proto
- Abstract
Loading...
